Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Oriana Zingaretti"'
Autor:
Simone Cerbasi, Alessio Bernasconi, Giovanni Balato, Federica Dimitri, Oriana Zingaretti, Gianclaudio Orabona, Raffaele Pascarella, Massimo Mariconda
Publikováno v:
The bonejoint journal. (2)
Aims The aims of this study were to assess the pre- and postoperative incidence of deep vein thrombosis (DVT) using routine duplex Doppler ultrasound (DUS), to assess the incidence of pulmonary embolism (PE) using CT angiography, and to identify the
Autor:
Caterina M. Magni, Giovanna Cola, Nicoletta Siragusa, Riccardo Sarzani, Massimiliano Serenelli, Oriana Zingaretti, Laura Giantomassi, Giovanni Bersigotti, R. Catalini, Mauro Pupita, Alessandro Rappelli, Flavia Carle, Paolo Dessì-Fulgheri, Pietro Ercolani, Rosaria Gesuita, Roberta Pasquini, Fabio Salvi, Domenico Mazzara, Diego Spagnolo
Publikováno v:
Journal of hypertension. 19(12)
OBJECTIVES AND DESIGN Angiotensinogen (AGT) gene variants influence angiotensinogen plasma levels in children and young adults. The angiotensinogen promoter (-6)A variant facilitates gene transcription in human tissues and it has been associated with
Angiotensin converting enzyme gene polymorphism and carotid atherosclerosis in a low-risk population
Autor:
Francesco Guazzarotti, Alessandro Rappelli, Riccardo Sarzani, Nicoletta Siragusa, R. Catalini, Paolo Dessì-Fulgheri, Oriana Zingaretti, Massimo Offidani, Simonetta Sturbini, Paola Tamburrini
Publikováno v:
Scopus-Elsevier
Angiotensin converting enzyme (ACE) insertion/deletion (I/D) polymorphism has been shown to be an independent risk factor for myocardial infarction and other cardiovascular diseases. The aim of the study was to investigate the relationship between AC
Autor:
Alessandro Rappelli, Paolo Dessì-Fulgheri, R. Catalini, Oriana Zingaretti, Emma Espinosa, Riccardo Sarzani, Simonetta Sturbini, Giuseppe Pupita, Francesco Guazzarotti
Publikováno v:
Journal of hypertension. 11(7)
OBJECTIVE: To investigate whether the hypotensive effects of angiotensin converting enzyme (ACE) inhibitors in comparison with those of calcium antagonist might be predicted by urinary kallikrein activity, a marker of the activity of the renal kallik